A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 45.7 KBAbraxis BioScience, Inc.Oct 19, 5:40 PM ET·0001181431-10-051419
- 45.7 KBAbraxis BioScience, Inc.Oct 19, 5:38 PM ET·0001181431-10-051416
- 45.7 KBAbraxis BioScience, Inc.Oct 19, 5:38 PM ET·0001181431-10-051415
- 45.7 KBAbraxis BioScience, Inc.Oct 19, 5:34 PM ET·0001181431-10-051410
- SC 13D/A82.3 KBAbraxis BioScience, Inc.Oct 18, 6:59 PM ET·0000950123-10-093953
- 48.5 KBAbraxis BioScience, Inc.Oct 18, 6:50 PM ET·0001209191-10-050700
- 8-K23.4 KBAbraxis BioScience, Inc.Oct 15, 3:46 PM ET·0001193125-10-230214
- 10-Q696.5 KBAbraxis BioScience, Inc.Aug 5, 4:55 PM ET·0001193125-10-179509
- 39.0 KBAbraxis BioScience, Inc.Jul 9, 4:36 PM ET·0001209191-10-037989
- SC 13D105.9 KBAbraxis BioScience, Inc.Jul 8, 5:29 PM ET·0000950123-10-064430
Insiders
10- CALHOUN KIRK KDirector
- CELGENE CORP /DE/10% Owner
- CHEN DAVIDDirector
- FOGELMAN MITCHELL KActing Chief Financial Officer
- Geehr EdExecutive VP Operations
- Hedley Mary LynneExecutive VP of Ops & CSO
- MOULDER LEON O JRDirector, President & CEO
- NIMER STEPHENDirector
- O'Toole David D.CFO & Executive VP
- Rodgers Richard JSenior Vice President and CFO
Tickers
No tickers on record
Addresses
business
11755 WILSHIRE BLVD., 20TH FLOOR
LOS ANGELES, CA, 90025
mailing
11755 WILSHIRE BLVD., 20TH FLOOR
LOS ANGELES, CA, 90025
Former Names
- Abraxis Biosciences, Inc.2008-09-26
- New Abraxis, Inc.2007-11-19